Royal Bank Of Canada Virios Therapeutics, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.86 - $2.42 $145 - $408	-169 Reduced 75.11%	56 $0
Q2 2023 Aug 14, 2023	BUY	$0.35 - $1.94 $78 - $436	225 New	225 $0
Q3 2022 Nov 14, 2022	BUY	$0.37 - $8.77 $12 - $289	33 New	33 $0
Q4 2021 Feb 14, 2022	SELL	$4.07 - $6.12 $4,070 - $6,120	-1,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.61 - $6.56 $4,610 - $6,560	1,000 New	1,000 $5,000

1.12M

Ticker VIRI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,330,400
Market Cap $81.4M
Description
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.